Original Research
Published on 25 May 2023
Prime editing strategies to mediate exon skipping in DMD gene
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1128557
- 5,461 views
- 3 citations
Type at least 3 characters
125 articles
Articles
Original Research
Published on 09 May 2023
Uncovering transcriptomic landscape alterations of CAN-2409 in in vitro and in vivo glioma models
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1140352
- 3,496 views
- 1 citation
Correction
Published on 03 Mar 2023
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1143748
- 1,584 views
Editorial
Published on 21 Feb 2023
Editorial: Global excellence in gene and cell therapy: Europe
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1154360
- 1,313 views
Review
Published on 17 Feb 2023
Anti-ROR1 CAR-T cells: Architecture and performance
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1121020
- 10,576 views
- 8 citations
Review
Published on 03 Feb 2023
AAV- based vector improvements unrelated to capsid protein modification
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1106085
- 15,789 views
- 7 citations
Review
Published on 19 Jan 2023
Barriers to Treg therapy in Europe: From production to regulation
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1090721
- 4,946 views
- 7 citations
Original Research
Published on 19 Jan 2023
Clinical experience: Outcomes of mesenchymal stem cell transplantation in five stroke patients
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2023.1051831
- 5,141 views
- 4 citations
Original Research
Published on 13 Dec 2022
Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.1052318
- 4,480 views
- 8 citations
Original Research
Published on 08 Dec 2022
AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.1018208
- 2,007 views
Original Research
Published on 29 Nov 2022
Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.939776
- 5,869 views
- 11 citations
Original Research
Published on 23 Nov 2022
Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.947729
- 1,567 views
- 3 citations
Review
Published on 08 Nov 2022
The polymerase δ-interacting protein family and their emerging roles in diseases
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.1026931
- 2,600 views
- 2 citations
Original Research
Published on 05 Oct 2022
CellDestiny: A RShiny application for the visualization and analysis of single-cell lineage tracing data
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.919345
- 3,239 views
- 4 citations
Correction
Published on 06 Sep 2022
Corrigendum: Mutations in FIGLA associated with premature ovarian insufficiency in a Chinese population
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.946150
- 1,072 views
Original Research
Published on 25 Aug 2022
COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2022.976604
- 3,849 views
- 13 citations